CB‐839 treatment had no effect on the growth of tumor organoids, but remarkably potentiated autologous CD8+ T cytotoxicity (determined by the quantification of organoid sizes) in 3 (Patient #1–3) out of 4 patient tumor tissues (Figure 2C,D; Table S1, Supporting Information). The gene discussed is CD8A; the disease is neoplasm.